论文信息 - Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model - 字舞流文

Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model

E. Longhi | R. Vanna | C. Morasso | M. Bellini | S. Mazzucchelli | M. Truffi | F. Corsi | D. Prosperi | L. Sorrentino | L. Sitia | S. Casati | R. Allevi | M. Sevieri | M. Monieri | A. Bonizzi | P. Zerbi | B. Marchini | R. Ottria | F. Andreata | F. Silva